Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Change in Receivables: 2018-2019

Historic Change in Receivables for DiaMedica Therapeutics (DMAC) over the last 2 years, with Dec 2019 value amounting to $159,000.

  • DiaMedica Therapeutics' Change in Receivables rose 160.46% to $159,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $43,000, marking a year-over-year decrease of 93.86%. This contributed to the annual value of -$133,000 for FY2024, which is 146.34% down from last year.
  • As of Q4 2019, DiaMedica Therapeutics' Change in Receivables stood at $159,000, which was up 135.49% from -$448,000 recorded in Q3 2019.
  • Over the past 5 years, DiaMedica Therapeutics' Change in Receivables peaked at $721,000 during Q3 2018, and registered a low of -$467,000 during Q2 2018.
  • For the 2-year period, DiaMedica Therapeutics' Change in Receivables averaged around $92,875, with its median value being $154,500 (2019).
  • Over the last 5 years, DiaMedica Therapeutics' Change in Receivables had its largest YoY gain of 160.46% in 2019, and its largest YoY loss of 162.14% in 2019.
  • Over the past 2 years, DiaMedica Therapeutics' Change in Receivables (Quarterly) stood at -$263,000 in 2018, then skyrocketed by 160.46% to $159,000 in 2019.
  • Its last three reported values are $159,000 in Q4 2019, -$448,000 for Q3 2019, and $182,000 during Q2 2019.